LYPRINOL
Live / Registered — Registered and renewed (as of 04 Apr 2024)
What this means for you
Registered since 20 Jan 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Jan 2024).
Record
- Serial number
- 78166424
- Registration number
- 2806625
- Mark type
- Word mark
- Filed
- 20 Sept 2002
- Published for opposition
- 28 Oct 2003
- Registered
- 20 Jan 2004
- Next maintenance due
- 20 Jan 2024
- Attorney of record
- Elizabeth A. Cominolli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammatory conditions, namely rheumatoid and osteoarthritis, asthma, psoriasis, colitis, lupus, cardio inflammation, inflammation of limbs resulting from injury; natural medicines containing extracts of shell fish and omega fatty acids, namely, pain relief medication
Owner
- Pharmalink International Limited, Central Hong Kong, KY
- Pharmalink International Limited, Central, KY
- Pharmalink International Limited, Central, KY
Prosecution history
- 04 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 04 Apr 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 04 Apr 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 27 Mar 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 27 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Nov 2023 — TEAS SECTION 8 & 9 RECEIVED
- 20 Jan 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 28 Dec 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 28 Dec 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 28 Dec 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 17 Dec 2013 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 28 Dec 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Dec 2013 — TEAS SECTION 8 & 9 RECEIVED
- 30 Sept 2011 — CORRECTION UNDER SECTION 7 - PROCESSED